Home » Teva to Acquire Ratiopharm in Deal Valued Near $5 Billion
Teva to Acquire Ratiopharm in Deal Valued Near $5 Billion
Teva Pharmaceutical Industries Ltd. won the bidding for generic-drug manufacturer
Ratiopharm, agreeing to buy the German firm in a deal valued at 3.63 billion euros ($4.97 billion).
MarketWatch
MarketWatch
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May